[go: up one dir, main page]

SI3354282T1 - Glikanski terapevtiki in z njimi povezani postopki - Google Patents

Glikanski terapevtiki in z njimi povezani postopki

Info

Publication number
SI3354282T1
SI3354282T1 SI201631129T SI201631129T SI3354282T1 SI 3354282 T1 SI3354282 T1 SI 3354282T1 SI 201631129 T SI201631129 T SI 201631129T SI 201631129 T SI201631129 T SI 201631129T SI 3354282 T1 SI3354282 T1 SI 3354282T1
Authority
SI
Slovenia
Prior art keywords
related methods
glycan therapeutics
glycan
therapeutics
methods
Prior art date
Application number
SI201631129T
Other languages
English (en)
Inventor
Maltzahn Geoffrey Von
Jared Silverman
Yvonne J. Yamanaka
Jack Milwid
John M. Geremia
Original Assignee
Kaleido Biosciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaleido Biosciences, Inc. filed Critical Kaleido Biosciences, Inc.
Publication of SI3354282T1 publication Critical patent/SI3354282T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
SI201631129T 2015-01-26 2016-01-13 Glikanski terapevtiki in z njimi povezani postopki SI3354282T1 (sl)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US201562108039P 2015-01-26 2015-01-26
US201562152007P 2015-04-23 2015-04-23
US201562152005P 2015-04-23 2015-04-23
US201562152017P 2015-04-23 2015-04-23
US201562152016P 2015-04-23 2015-04-23
US201562152011P 2015-04-23 2015-04-23
US201562217002P 2015-09-10 2015-09-10
US201562216995P 2015-09-10 2015-09-10
US201562216997P 2015-09-10 2015-09-10
US201562216993P 2015-09-10 2015-09-10
US201562238110P 2015-10-06 2015-10-06
US201562238112P 2015-10-06 2015-10-06
EP17206409.9A EP3354282B1 (en) 2015-01-26 2016-01-13 Glycan therapeutics and related methods thereof

Publications (1)

Publication Number Publication Date
SI3354282T1 true SI3354282T1 (sl) 2021-07-30

Family

ID=55349947

Family Applications (2)

Application Number Title Priority Date Filing Date
SI201630020T SI3071235T1 (sl) 2015-01-26 2016-01-13 Terapevtiki glikana in s tem povezane metode
SI201631129T SI3354282T1 (sl) 2015-01-26 2016-01-13 Glikanski terapevtiki in z njimi povezani postopki

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI201630020T SI3071235T1 (sl) 2015-01-26 2016-01-13 Terapevtiki glikana in s tem povezane metode

Country Status (23)

Country Link
US (6) US20170151268A1 (sl)
EP (3) EP3862002A1 (sl)
JP (3) JP2018502926A (sl)
KR (1) KR20170122753A (sl)
CN (1) CN107427528B (sl)
AU (2) AU2016212030B2 (sl)
BR (1) BR112017015614B1 (sl)
CA (1) CA2973617A1 (sl)
CL (1) CL2017001901A1 (sl)
DK (2) DK3071235T3 (sl)
EA (1) EA201791702A1 (sl)
ES (2) ES2857557T3 (sl)
IL (3) IL253195B (sl)
LT (2) LT3071235T (sl)
MX (2) MX2017009589A (sl)
MY (1) MY188879A (sl)
PH (1) PH12017501342B1 (sl)
PL (2) PL3354282T3 (sl)
PT (2) PT3071235T (sl)
SG (2) SG11201706033XA (sl)
SI (2) SI3071235T1 (sl)
WO (1) WO2016122889A1 (sl)
ZA (1) ZA201704735B (sl)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3228982A1 (en) 2014-07-09 2016-01-14 Dsm Nutritional Products, Llc Oligosaccharide compositions and methods for producing thereof
CN107466212A (zh) 2015-01-26 2017-12-12 卡德纳生物股份有限公司 使用动物饲料的寡糖组合物以及其制造方法
EP3862002A1 (en) 2015-01-26 2021-08-11 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
US9492473B2 (en) * 2015-01-26 2016-11-15 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
ES2895725T3 (es) 2015-04-23 2022-02-22 Kaleido Biosciences Inc Compuestos terapéuticos de glicano y métodos de tratamiento
MX2018002301A (es) * 2015-08-25 2018-08-16 Kaleido Biosciences Inc Composiciones de glucano y usos de las mismas.
EP3484483B1 (en) 2016-07-13 2023-03-08 Kaleido Biosciences, Inc. Glycan compositions and methods of use
US11959125B2 (en) * 2016-09-15 2024-04-16 Sun Genomics, Inc. Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample
EP4295840A3 (en) 2016-12-06 2024-03-13 DSM Nutritional Products, LLC Glycan polymers and related methods thereof
US11529380B2 (en) 2016-12-23 2022-12-20 MURDOCH CHILDREN'S RESEARCH INSTITUTE Parkville Methods and compositions for determining, and for minimizing, the likelihood of development of allergy in infants
CA3059265A1 (en) * 2017-04-07 2018-10-11 Children's Hospital Medical Center Treatment of inflammatory bowel diseases with 2'-fucosyllactose compounds
AU2018278276B2 (en) * 2017-06-02 2024-02-15 Goodgut S.L. Grape skin for use in the treatment of dysbiosis
EP3651776A1 (en) 2017-07-13 2020-05-20 Kaleido Biosciences, Inc. Glycan compositions and methods of use
TWI640314B (zh) * 2017-08-22 2018-11-11 長庚生物科技股份有限公司 戈氏副擬桿菌用於降低胰島素抗性及提升葡萄糖耐受性之用途
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
JP6967404B2 (ja) * 2017-08-31 2021-11-17 雪印メグミルク株式会社 アッカーマンシア・ムシニフィラ増加促進用組成物
US11898184B2 (en) 2017-09-07 2024-02-13 Sweet Sense Inc. Low glycemic sugar composition
CN111093642A (zh) * 2017-09-13 2020-05-01 In原料公司 Pd-l1抑制的表达和pd1增强的表达
US10894030B2 (en) 2017-09-13 2021-01-19 In Ingredients, Inc. Methods and compositions for the inhibition of the expression of PD-L1 in tumor cells
US20200246411A1 (en) * 2017-09-29 2020-08-06 Adithya SAGAR Anti-diarrhoeal herbal compositions
JP7576375B2 (ja) * 2017-11-03 2024-10-31 カレイド・バイオサイエンシズ・インコーポレイテッド グリカン調製物及び高アンモニア血症のための使用方法
EP3862006A1 (en) 2017-11-03 2021-08-11 Kaleido Biosciences, Inc. Glycan preparations for the treatment of infection
EP3704161A1 (en) 2017-11-03 2020-09-09 Kaleido Biosciences, Inc. Methods of producing glycan polymers
WO2019092896A1 (ja) * 2017-11-08 2019-05-16 アサヒグループホールディングス株式会社 アッカーマンシア・ムシニフィラ増殖材
EP3741376A4 (en) * 2017-12-15 2021-09-22 Green Cross WellBeing Corporation PROBIOTICS TO INHIBIT AND PREVENT THE DEVELOPMENT OF KIDNEY DISEASES AND COMPOSITIONS TO INHIBIT AND PREVENT THE EVOLUTION OF KIDNEY DISEASES INCLUDING THEM
US20230158084A1 (en) * 2018-01-05 2023-05-25 California Institute Of Technology Probiotics, metabolites, and uses thereof
CN108125975A (zh) * 2018-01-29 2018-06-08 广东省农业科学院动物卫生研究所 野漆树苷在制备抗微小隐孢子虫药物中的应用
CN108777998B (zh) * 2018-02-12 2022-03-11 天津天狮生物发展有限公司 一种调节人体肠道功能的复合益生元及其应用
EP3755343A1 (en) * 2018-02-22 2020-12-30 Gnubiotics Sciences SA New process of preparation of glycan composition & uses thereof
EP3530281A1 (en) * 2018-02-22 2019-08-28 Gnubiotics Sciences Sàrl New process of preparation of glycan compositions & uses thereof
CN108760900A (zh) * 2018-03-20 2018-11-06 华南理工大学 一种测定羧甲基纤维素钠取代度的顶空气相色谱法
CN108567901B (zh) * 2018-04-27 2021-07-23 美益添生物医药(武汉)有限公司 一种提高肠道中scfa产生菌的复合制剂及制备方法与应用
WO2019205942A1 (zh) * 2018-04-27 2019-10-31 美益添生物医药(武汉)有限公司 一种提高肠道中scfa产生菌的复合制剂及制备方法与应用
CN108403930B (zh) * 2018-04-27 2021-08-20 美益添生物医药(武汉)有限公司 一种提高肠道中akk菌/致病菌比值的复合制剂及制备方法与应用
JP7195067B2 (ja) * 2018-06-20 2022-12-23 花王株式会社 ロズマリン酸誘導体又はその塩
AU2019306649A1 (en) * 2018-07-19 2021-02-04 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment
US11918602B2 (en) 2018-08-10 2024-03-05 Simeon Investment, Inc. Methods for reducing cholesterol with superabsorbent materials
WO2020033796A1 (en) * 2018-08-10 2020-02-13 Metagenics, Inc. Method of treating inflammatory bowel disease
US11925660B2 (en) 2018-08-10 2024-03-12 Simeon Investment, Inc. Treatment for obesity with superabsorbent materials
JP7223477B2 (ja) * 2018-10-10 2023-02-16 花王株式会社 Ｔｒｐｖ４活性抑制剤
IT201800009755A1 (it) * 2018-10-24 2020-04-24 Berardino Vaira Nuovi probiotici utili per eradicare l'infezione da helicobacter pylori
CN113260635B (zh) 2018-11-08 2023-10-31 Dsm营养产品有限责任公司 寡糖组合物及其使用方法
KR102196047B1 (ko) * 2018-11-14 2020-12-29 건국대학교 글로컬산학협력단 메타중아황산염을 포함하는 사료 원료 보존용 조성물 및 이를 이용한 사료의 제조방법
TWI692777B (zh) * 2018-11-16 2020-05-01 長庚醫療財團法人高雄長庚紀念醫院 智能化急性腎損傷藥物警示系統
PL3886603T3 (pl) * 2018-11-26 2023-06-26 Purac Biochem B.V. Kompozycja konserwująca żywność w postaci cząstek
ES2763874B2 (es) * 2018-11-30 2020-10-13 Consejo Superior Investigacion Phascolarctobacterium faecium para su uso en la prevencion y tratamiento de la obesidad y sus comorbilidades
CN109633011A (zh) * 2018-12-29 2019-04-16 中山百灵生物技术有限公司 一种新的甘氨酸含量的检测方法
WO2020157321A1 (en) 2019-01-31 2020-08-06 Gnubiotics Sciences Sa Compositions derived from gastrointestinal tract mucins
US11788155B1 (en) * 2019-06-06 2023-10-17 University Of South Florida Lung microbiome isolation and cultivation
CN110115713A (zh) * 2019-06-20 2019-08-13 郑州康金瑞健康产业有限公司 一种止鼾液及其制备方法
EP3999084A4 (en) * 2019-07-19 2023-07-12 Finch Therapeutics Holdings LLC METHODS AND PRODUCTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
US20210070890A1 (en) * 2019-09-06 2021-03-11 Serum Institute Of India Private Limited Method for obtaining purified bacterial polysaccharides
WO2021067167A1 (en) * 2019-10-03 2021-04-08 The Regents Of The University Of Michigan Clostrodioides difficile treatment
MX2022004635A (es) * 2019-10-21 2022-05-10 Biofermin Pharmaceutical Co Ltd Agente reductor de toxina uremica.
KR102470108B1 (ko) * 2020-01-02 2022-11-23 삼육대학교산학협력단 부티리시모나스 속 균주를 유효성분으로 포함하는 당뇨병 예방 또는 치료용 조성물
KR102470116B1 (ko) * 2020-01-02 2022-11-23 삼육대학교산학협력단 부티리시모나스 속 균주를 유효성분으로 포함하는 비알콜성 지방간 질환의 예방 또는 치료용 약학적 조성물
CN115551873A (zh) * 2020-03-13 2022-12-30 帝斯曼知识产权资产管理有限公司 调节胃肠道微生物代谢途径和代谢物的方法
US20210345634A1 (en) * 2020-05-07 2021-11-11 Christopher Burns Dissolving coffee beads
CN115720490A (zh) * 2020-05-29 2023-02-28 嘉吉公司 包含葡萄糖寡糖的组合物及其制备方法和用途
JP2023534047A (ja) * 2020-07-17 2023-08-07 ディーエスエム・ニュートリショナル・プロダクツ・エルエルシー オリゴ糖組成物及び使用方法
CN111671911B (zh) * 2020-07-24 2021-08-10 刘艳 一种治疗盆底失驰缓型便秘的药物组合物及其制备方法
CN111999411B (zh) * 2020-09-01 2022-08-09 山东省农业科学院农业质量标准与检测技术研究所 果蔬中矢车菊素及3种花色苷的高效液相色谱检测方法
CA3196600A1 (en) * 2020-09-25 2022-03-31 Dsm Nutritional Products, Llc Oligosaccharide compositions and methods of use
JP2022092966A (ja) * 2020-12-11 2022-06-23 トヨタ自動車株式会社 ジペプチジルペプチダーゼｉｖ阻害剤、機能性表示食品
KR102294437B1 (ko) * 2021-02-17 2021-08-27 주식회사 메디오젠 영유아 유래 유산균 락토바실러스 플란타럼 mg4553 및 이를 포함하는 장 건강 증진, 항산화 및 항비만용 조성물
KR102294442B1 (ko) * 2021-02-17 2021-08-27 주식회사 메디오젠 영유아 유래 유산균 락토바실러스 플란타럼 mg4555 및 이를 포함하는 장 건강 증진, 항산화 및 항비만용 조성물
EP4305074A1 (en) 2021-03-08 2024-01-17 Exopolymer, Inc. Biopolymers for topical use
CN113073066B (zh) * 2021-04-16 2022-01-04 段云峰 罗伊氏乳杆菌及其应用、组合物、药物和食品
CN113430242B (zh) * 2021-07-07 2022-02-18 北京浩鼎瑞生物科技有限公司 一种筛选对肠道微生态具有促进作用的提取物方法及将其用于靶向筛选益生菌的应用
CA3226881A1 (en) * 2021-07-26 2023-02-02 Suzanne AHMED Drug delivery platform for delivery of therapeutics and methods of use and manufacture thereof
RU2770882C1 (ru) * 2021-08-23 2022-04-25 Федеральное государственное бюджетное образовательное учреждение высшего образования "Белгородский государственный аграрный университет имени В.Я. Горина" Способ получения хлорофиллсодержащего продукта в качестве пищевого красителя
CN113797183B (zh) * 2021-11-05 2022-08-19 安徽医科大学第一附属医院 五味子酚在制备防治霉酚酸所致腹泻药物中的应用
CN114166961B (zh) * 2021-11-17 2022-11-22 西南大学 一种测定柑桔汁产品中酚类化合物及其前处理的方法
CN114376939B (zh) * 2021-12-27 2023-08-25 广州丸美生物科技有限公司 一种多糖组合物及其制备方法与应用
EP4260864A1 (en) * 2022-04-13 2023-10-18 Bluestone Pharma GmbH Product comprising probiotics and isomaltulose and method of its production
WO2024192188A1 (en) * 2023-03-13 2024-09-19 University Of Connecticut Agents and methods for modulating clostridioides difficile infection
US12144821B1 (en) 2024-02-02 2024-11-19 King Faisal University Selective 3-prenyl 5-methyl ether, 7-o-rhamnoside flavone for the treatment of hepatic cancer
CN117815443B (zh) * 2024-03-05 2024-05-17 江苏宝众宝达药业股份有限公司 一种保护透析血管通路的外用敷料及其制备方法
CN118340728B (zh) * 2024-06-18 2024-09-06 山东天宇生物科技有限公司 一种复合盐酸林可霉素可溶性粉及其制备方法
CN118845821A (zh) * 2024-09-23 2024-10-29 四川大学 昙花提取物在制备治疗/改善肠道疾病的保健食品或药物中的应用

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2027904A (en) 1933-02-16 1936-01-14 Int Suiker En Alcohol Cie Inte Method of polymerizing monosaccharides
US2436967A (en) 1942-04-01 1948-03-02 Corn Prod Refining Co Polymerization of sugars
US2719179A (en) 1951-01-25 1955-09-27 Mora Peter Tibor Branched-chain carbohydrate polymers and their preparation
US3766165A (en) 1966-08-17 1973-10-16 Pfizer Polysaccharides and their preparation
US3876794A (en) 1972-12-20 1975-04-08 Pfizer Dietetic foods
US3973049A (en) 1974-03-14 1976-08-03 General Foods Corporation Method of mixing flavors and fixed composition comprising derivatized synthetic polysaccharides
US4965354A (en) 1988-02-26 1990-10-23 Taito Company, Ltd. Process for producing a condensed polysaccharide
US5667593A (en) 1989-01-26 1997-09-16 Cultor Ltd. Modified polydextrose and process therefor
TW203106B (sl) 1991-07-18 1993-04-01 Textilma Ag
JPH06121693A (ja) 1992-08-25 1994-05-06 Akebono Brake Res & Dev Center Ltd 高重合度オリゴ糖の製造法
FR2697023B1 (fr) 1992-10-16 1994-12-30 Roquette Freres Polymère soluble hypocalorique du glucose et procédé de préparation de ce polymère .
US5843922A (en) 1994-07-29 1998-12-01 Fuisz Technologies Ltd. Preparation of oligosaccharides and products therefrom
US6475552B1 (en) 1997-03-19 2002-11-05 Danisco Finland Oy Polymerization of mono and disaccharides using low levels of polycarboxylic acids
DK0968232T3 (da) 1997-03-19 2004-05-03 Danisco Usa Inc Polymerisation af mono- og disaccharider ved anvendelse af lave niveauer af mineralsyrer
JP3093194B2 (ja) * 1998-04-30 2000-10-03 韓国科学技術研究院 新規のペリヌス属菌株から分離した免疫増強活性多糖類物質及びその使用
US6251878B1 (en) * 1998-07-10 2001-06-26 Board Of Regents, The University Of Texas System Inhibition of UV-induced immune suppression and interleukin-10 production by cytoprotective tamarind oligosaccharides
DE19860376A1 (de) 1998-12-28 2000-07-06 Aventis Res & Tech Gmbh & Co Alpha-1,4 Glucanketten enthaltende Polysaccharide sowie Verfahren zu ihrer Herstellung
US6977245B2 (en) 1999-04-12 2005-12-20 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxynucleotide and its use to induce an immune response
CA2391966A1 (en) 1999-11-24 2001-05-31 Massachusetts Institute Of Technology Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries
US7608291B2 (en) 2000-03-10 2009-10-27 Mars, Inc. Treatment of infection in animals
JP2004520318A (ja) 2000-12-27 2004-07-08 エヌ・ヴイ・ヌートリシア オリゴ糖を含有する健康増進作用を有する栄養組成物
DE10147100A1 (de) * 2001-09-25 2003-04-17 Numico Res B V Antiinfektive Kohlenhydrate
NZ515869A (en) 2001-11-30 2003-09-26 Med Chem Ingredients Ltd Compositions and methods for animal treatment comprising gluco- and isomalto- oligosaccharides
GB0211118D0 (en) * 2002-05-15 2002-06-26 Polonelli Luciano Vaccines
US20060008574A1 (en) 2002-06-07 2006-01-12 Begli Alireza H Galactosyl isomalt, method for production and use thereof
US20060014717A1 (en) 2002-06-28 2006-01-19 Glykos Finland Oy Therapeutic compositions for use in prophylaxis or treatment of diarrheas
MXPA05000872A (es) 2002-07-23 2005-04-28 Neose Technologies Inc Sintesis de glicoproteinas utilizando glicosiltransferasas bacterianas.
MXPA05002116A (es) 2002-08-23 2005-06-03 Du Pont Utilizacion de productos de almidon para produccion biologica por fermentacion.
FR2844453B1 (fr) * 2002-09-13 2006-05-19 Agronomique Inst Nat Rech Utilisation de pre-biotiques pour la prevention de l'installation du diabete de type ii
US20040052915A1 (en) 2002-09-13 2004-03-18 Carlson Ting L. Use of low glycemic index sweeteners in food and beverage compositions
FI20021772A (fi) 2002-10-04 2004-04-05 Biotie Therapies Oyj Uudet hiilihydraattikoostumukset ja menetelmä niiden valmistamiseksi
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
US7291607B2 (en) * 2003-05-20 2007-11-06 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Isomaltooligosaccharides from Leuconostoc as neutraceuticals
ATE360682T1 (de) 2003-06-30 2007-05-15 Clasado Inc Neue galactooligosaccharidzusammensetzung und herstellung davon
EP1634599A1 (en) 2004-08-20 2006-03-15 N.V. Nutricia Iimmune stimulatory infant nutrition
FR2874825B1 (fr) * 2004-09-08 2006-12-08 Genibio Sarl Utilisations d'oligosaccharides prebiotiques benefiques pour la flore vaginale
US20060093592A1 (en) 2004-10-04 2006-05-04 Nutracea Synbiotics
DE102004058811A1 (de) 2004-12-07 2006-06-08 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Herstellung von Zuckeralkoholen
WO2007010084A2 (en) 2005-07-15 2007-01-25 Johannes Savolainen Immunostimulatory oligo- and polysaccharides and uses thereof
EP1916908A1 (en) 2005-07-27 2008-05-07 Cantabria Group LCC Phosphorylated glucomannane polysaccharides containing 1-6 and 1-2 linkages increase weight gain in poultry
CA2620832C (en) 2005-08-25 2012-01-24 Archer-Daniels-Midland Company Use of dextrin in animal feeds
MY144556A (en) 2005-10-24 2011-09-30 Nestec Sa Dietary fiber formulation and method of administration
US8993039B2 (en) 2006-01-25 2015-03-31 Tate & Lyle Ingredients Americas Llc Fiber-containing carbohydrate composition
US8057840B2 (en) 2006-01-25 2011-11-15 Tate & Lyle Ingredients Americas Llc Food products comprising a slowly digestible or digestion resistant carbohydrate composition
US7915235B2 (en) * 2006-03-20 2011-03-29 Brian Dieckgraefe High affinity ligands bind to clostridium difficile toxin A
US20090163427A1 (en) 2006-04-10 2009-06-25 Aleksander Vladimirovich Dikovskiy Pharmaceutical Composition of Enterosorbent and Prebiotics, Dosage Forms, and the Method for Prevention and Treatment of Gastrointestinal Disorders
EP1887017A1 (en) 2006-08-09 2008-02-13 Friesland Brands B.V. Prebiotic carbohydrate
FI20065593L (fi) 2006-09-26 2008-03-27 Valio Oy Menetelmä galakto-oligosakkarideja sisältävien tuotteiden valmistamiseksi ja niiden käyttö
US20130216693A1 (en) 2007-01-24 2013-08-22 Tate & Lyle Ingredients Americas Llc Fiber-containing carbohydrate composition
ES2304223B2 (es) 2007-03-08 2009-05-01 Universidad De Sevilla Nuevos caramelos con elevado contenido en oligosacaridos prebioticos, procedimiento de preparacion y utilizacion.
US8324375B2 (en) * 2007-04-26 2012-12-04 Hayashibara Co., Ltd. Branched α-glucan, α-glucosyltransferase which forms the glucan, their preparation and uses
US8197872B2 (en) 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
WO2008156354A1 (en) 2007-06-21 2008-12-24 N.V. Nutricia Modulation of intestinal flora of hiv patients
CN101951794B (zh) * 2007-12-21 2016-11-02 N.V.努特里奇亚 鞘髓磷脂和非消化性碳水化合物改善肠道微生物群的用途
BRPI0913441A8 (pt) 2008-06-09 2017-10-03 Temple Inland Composição prebiótica e métodos de produção e uso da mesma
PT2355670E (pt) 2008-12-10 2013-07-04 Fugeia Nv Produto alimentar contendo arabinoxilano e oligossacáridos
AU2010223965A1 (en) 2009-03-13 2011-10-06 Dsm Food Specialties Usa Inc. Prebiotic oligosaccharides
KR101783383B1 (ko) 2009-05-07 2017-09-29 테이트 ＆ 라일 인그레디언츠 프랑스 에스에이에스 알파-(1,2)-분지형 알파-(1,6) 올리고덱스트란을 제조하기 위한 조성물 및 방법
AU2009347008B2 (en) 2009-05-27 2013-08-15 Clasado Limited Method of preventing diarrhoea
PL2453902T3 (pl) 2009-07-15 2014-01-31 Nutricia Nv Mieszanina niepodatnych na trawienie oligosacharydów do stymulowania układu immunologicznego
US8691792B2 (en) 2009-08-05 2014-04-08 Nestec Sa Methods and compositions for improving gastrointetinal health
CN102892421A (zh) * 2010-03-10 2013-01-23 伊诺沃生物公司 用于治疗代谢病症的包含葡甘露聚糖、黄原胶和藻酸盐的食物
EP2401925B1 (fr) 2010-06-29 2014-05-07 Rosebud AG Produit prebiotique et procede de fabrication
US20140187474A1 (en) 2011-02-16 2014-07-03 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic use of mucin glycans
BR112013022047B1 (pt) 2011-02-28 2020-11-17 Cadena Bio, Inc catalisadores de ácidos poliméricos e seus usos
MX2013013028A (es) 2011-05-13 2013-12-02 Glycom As Metodo para generar oligosacaridos de leche humana (hmo) o precursores de los mismos.
US20140328997A1 (en) 2011-09-08 2014-11-06 Rutgers, The State University Of New Jersey Production of Enriched Products
WO2013082562A1 (en) 2011-11-30 2013-06-06 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
FR2987360B1 (fr) 2012-02-28 2014-03-28 Roquette Freres Maltodextrines hyperbranchees hypo-glycemiantes
EP2666788A1 (en) 2012-05-21 2013-11-27 Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO Glucan fibre
EP2888044A4 (en) 2012-08-24 2016-05-04 Midori Usa Inc POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGING CELLULOSIC MATERIALS USING SAID CATALYSTS
US20150202607A1 (en) 2012-08-24 2015-07-23 Midori Renewables, Inc. Polymeric and solid-supported catalysts, and methods of digesting cellulosic materials using such catalysts
US20150238948A1 (en) 2012-08-24 2015-08-27 Midori Renewables, Inc. Polymeric and solid-supported catalysts, and methods of digesting lignin-containing materials using such catalysts
US9238845B2 (en) 2012-08-24 2016-01-19 Midori Usa, Inc. Methods of producing sugars from biomass feedstocks
ES2709599T3 (es) 2013-02-21 2019-04-16 Jennewein Biotechnologie Gmbh Oligosacáridos fucosilados sintéticos o recombinantes para uso en el tratamiento de infecciones
US20160032038A1 (en) 2013-03-14 2016-02-04 Midori Usa, Inc. Polymeric ionic salt catalysts and methods of producing thereof
EP2983514A4 (en) 2013-03-15 2017-03-15 Cargill, Incorporated Carbohydrate compositions
WO2015153841A1 (en) 2014-04-04 2015-10-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
CA3228982A1 (en) 2014-07-09 2016-01-14 Dsm Nutritional Products, Llc Oligosaccharide compositions and methods for producing thereof
CN107466212A (zh) 2015-01-26 2017-12-12 卡德纳生物股份有限公司 使用动物饲料的寡糖组合物以及其制造方法
EP3862002A1 (en) * 2015-01-26 2021-08-11 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
US9492473B2 (en) 2015-01-26 2016-11-15 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
WO2016122885A1 (en) 2015-01-26 2016-08-04 Midori Usa, Inc. Oligosaccharide compositions for use in nutritional compositions, and methods of producing thereof
EP3250054A4 (en) 2015-01-26 2018-08-15 Cadena Bio, Inc. Oligosaccharide compositions for use as food ingredients and methods of producing thereof
RU2017134547A (ru) 2015-04-23 2019-04-09 Калейдо Байосайенсиз, Инк. Регуляторы микробиома и соответствующие варианты их применения
ES2895725T3 (es) 2015-04-23 2022-02-22 Kaleido Biosciences Inc Compuestos terapéuticos de glicano y métodos de tratamiento
WO2017083520A1 (en) 2015-11-13 2017-05-18 Cadena Bio, Inc. Animal therapeutic and feed compositions and methods of use
US11484547B2 (en) * 2018-01-08 2022-11-01 Performance Labs PTE. LTD. Compositions and methods for cholesterol, glucose and microbiome control

Also Published As

Publication number Publication date
BR112017015614A2 (pt) 2018-04-10
MX381376B (es) 2025-03-12
PH12017501342A1 (en) 2017-12-18
SG11201706033XA (en) 2017-08-30
BR112017015614B1 (pt) 2023-05-09
JP2018502926A (ja) 2018-02-01
EP3862002A1 (en) 2021-08-11
CL2017001901A1 (es) 2018-07-06
JP2021063079A (ja) 2021-04-22
EA201791702A1 (ru) 2018-04-30
SI3071235T1 (sl) 2018-04-30
ZA201704735B (en) 2019-02-27
MY188879A (en) 2022-01-12
CN107427528B (zh) 2022-09-23
US9757403B2 (en) 2017-09-12
EP3354282A1 (en) 2018-08-01
MX2020001555A (es) 2021-04-09
US20170151268A1 (en) 2017-06-01
US20210113596A1 (en) 2021-04-22
CA2973617A1 (en) 2016-08-04
DK3071235T3 (en) 2018-02-19
PL3071235T3 (pl) 2018-05-30
ES2857557T3 (es) 2021-09-29
JP2023022175A (ja) 2023-02-14
CN107427528A (zh) 2017-12-01
AU2016212030A1 (en) 2017-07-20
IL277342B (en) 2022-02-01
US10314853B2 (en) 2019-06-11
LT3071235T (lt) 2018-04-25
SG10202103777UA (en) 2021-05-28
PT3071235T (pt) 2018-02-21
IL277342A (en) 2020-10-29
IL285179A (en) 2021-08-31
KR20170122753A (ko) 2017-11-06
EP3354282B1 (en) 2020-12-30
US20170151269A1 (en) 2017-06-01
US20200093851A1 (en) 2020-03-26
PL3354282T3 (pl) 2021-07-05
AU2016212030B2 (en) 2021-06-17
ES2659648T3 (es) 2018-03-16
US20180147222A1 (en) 2018-05-31
US20200093845A1 (en) 2020-03-26
EP3071235A1 (en) 2016-09-28
IL253195A0 (en) 2017-08-31
PT3354282T (pt) 2021-03-18
AU2021203605A1 (en) 2021-07-01
PH12017501342B1 (en) 2022-11-16
IL253195B (en) 2021-08-31
US10702542B2 (en) 2020-07-07
EP3071235B1 (en) 2017-12-13
WO2016122889A1 (en) 2016-08-04
US11229660B2 (en) 2022-01-25
US10881676B2 (en) 2021-01-05
MX2017009589A (es) 2018-06-20
LT3354282T (lt) 2021-04-12
DK3354282T3 (da) 2021-03-08

Similar Documents

Publication Publication Date Title
IL277342B (en) Glycan therapy and related methods
HK1251455A1 (zh) 聚糖治療劑和治療方法
ZA201804070B (en) Eif4-a-inhibiting compounds and methods related thereto
GB2546350B (en) Compositions and methods
IL257958A (en) Glyco-directed healing
GB201718876D0 (en) Antithrombin-heparin compositions and methods
IL253161A0 (en) Glycan conjugates and methods for using them
HK1250146A1 (zh) 抗前-bcr拮抗劑和方法
HK1247111A1 (zh) 多肽治療劑和其用途
HK1247122A1 (zh) 組合及其用途
IL254241A0 (en) Etv2 and its uses
GB201517786D0 (en) Methods and materials
GB201512996D0 (en) Compositions and methods
GB201514413D0 (en) Compositions and methods
IL256261B (en) Hide1 compositions and methods
GB2545167B (en) Cloches and use thereof
GB201522554D0 (en) Methods and compositions
GB201518167D0 (en) Methods and compositions
GB201514415D0 (en) Compositions and methods
GB201505884D0 (en) Transcription factors and uses thereof
PT2923578T (pt) Método para a produção de um produto alimentar